bortezomib
General
Pronunciation:
bor-tez-o-mib

Trade Name(s)
- Velcade
Ther. Class.
Pharm. Class.
proteasome inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Bortezomib." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/51837/1/bortezomib.
Vallerand AHA, Sanoski CAC, Quiring CC. Bortezomib. Davis's Drug Guide. F.A. Davis Company; 2023. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/51837/1/bortezomib. Accessed September 28, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Bortezomib. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/51837/1/bortezomib
Vallerand AHA, Sanoski CAC, Quiring CC. Bortezomib [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 September 28]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/51837/1/bortezomib.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - bortezomib
ID - 51837
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/51837/1/bortezomib
PB - F.A. Davis Company
ET - 18
DB - Nursing Central
DP - Unbound Medicine
ER -